Impact of lipid‐lowering therapy on the prevalence of dyslipidaemia in patients at high‐risk of cardiovascular events in UK primary care – a retrospective database study-Reference-Cited by-同舟云学术

Impact of lipid‐lowering therapy on the prevalence of dyslipidaemia in patients at high‐risk of cardiovascular events in UK primary care – a retrospective database study

Published:2013-08-14 Issue:12 Volume:67 Page:1228-1237
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Jameson K.¹,Amber V.¹²,D'Oca K.¹,Mills D.³,Giles A.⁴,Ambegaonkar B.⁵

Affiliation:

1. Merck Sharp & Dohme Ltd Herts UK

2. Imperial College London UK

3. Independent Consultant Plainsboro NJ USA

4. Value Demonstration Practice Oxford PharmaGenesis™ Ltd Oxford UK

5. Merck & Co Inc. Whitehouse Station NJ USA

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.12238

Reference33 articles.

1. British Heart Foundation.Heart statistics.http://www.bhf.org.uk/research/heart-statistics.aspx(accessed 14 November 2012).

2. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey

3. General Medical Services – contractural changes 2013/2014.http://www.dh.gov.uk/health/2012/12/gp-contract-proposals/(accessed 19 February 2013).

4. Joint British recommendations on prevention of coronary heart disease in clinical practice;British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association;Heart,1998

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study;BMC Endocrine Disorders;2023-12-05

2. Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus;European Heart Journal - Quality of Care and Clinical Outcomes;2023-05-24

3. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa;BMC Endocrine Disorders;2021-08-08

4. Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination;American Journal of Cardiovascular Drugs;2019-02-04

5. Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly;Drugs in R&D;2018-11-17